Beyond Air, Inc. XAIR
Medical/Dental Instruments · data as of November 13, 2026
Beyond Air, Inc. (XAIR) is a healthcare company listed in the US with a market value of about $4M. In the twelve months to September 30, 2026 it had revenue of $8M and net income of -$33M, a net margin of -407.3%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 54% a year, a 5-year average ROIC of -158%.
About Beyond Air
Beyond Air is listed in the US and classified in medical/dental instruments. Revenue went from $8M in 2019 to $8M in 2026, a decline of about 0.1% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 454% over three years (dilution for shareholders). It spends 133% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $8M | $4M | $1M | — | — | $873000 | $1M | $8M | — | — |
| Net income | -$33M | -$33M | -$47M | -$60M | -$56M | -$43M | -$23M | -$20M | -$7M | -$11M | -$18M |
| Free cash flow | -$21M | -$19M | -$44M | -$62M | -$37M | -$25M | -$21M | -$15M | $1M | -$9M | -$7M |
| EPS (diluted) | $-20.10 | $-20.05 | $-68.85 | $-182.00 | $-186.00 | $-168.00 | $-127.00 | $-178.00 | $-77.00 | $14.00 | $-301.00 |
| Net margin | -407.3% | -433.0% | -1258.4% | -5197.8% | — | — | -2620.3% | -1434.6% | -84.9% | — | — |
| ROIC | — | -307.2% | -227.5% | -110.9% | -100.8% | -42.7% | -47.0% | -98.4% | -60.0% | 508.7% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $20.00, 839% above the current price; targets range from $10.00 to $30.00; the consensus rating is “Strong buy”; expected EPS is $-26.89 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Beyond Air pay a dividend?
Not currently.
Is Beyond Air a good stock to buy?
We do not give buy or sell advice. Beyond Air scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.